Treatment of Primary Pulmonary Hypertension with Oral Sildenafil

Publisher： Karger

E-ISSN： 1423-0356|71|2|192-194

ISSN： 0025-7931

Source： Respiration, Vol.71, Iss.2, 2004-03, pp. : 192-194

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sildenafil improves renal function in patients with pulmonary arterial hypertension

By  

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 80, Iss. 2, 2015-08 ,pp. : 235-241

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cost-minimization analysis of treprostinil vs. epoprostenol as an alternate to oral therapy non-responders for the treatment of pulmonary arterial hypertension

By Narine L.   Hague L. K.   Walker J. H.   Vicente C.   Schilz R.   Desjardins O.   Einarson T. R.   Iskedjian M.  

Current Medical Research and Opinion, Vol. 21, Iss. 12, 2005-12 ,pp. : 2007-2016

Informa Healthcare

Access to resources Recommend Favorite

Favorable Outcome of Pregnancy with an Elective Use of Epoprostenol and Sildenafil in Women with Severe Pulmonary Hypertension

By  

Cardiology, Vol. 115, Iss. 3, 2010-02 ,pp. : 205-208

Karger

Access to resources Recommend Favorite

Pharmacokinetic interactions among imatinib, bosentan and sildenafil, and their clinical implications in severe pulmonary arterial hypertension

By  

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 80, Iss. 1, 2015-07 ,pp. : 75-85

John Wiley & Sons Inc

Access to resources Recommend Favorite

Sildenafil Therapy for Interferon-β-1a-Induced Pulmonary Arterial Hypertension: A Case Report

By  

Cardiology, Vol. 120, Iss. 4, 2012-01 ,pp. : 187-189

Karger

Access to resources Recommend Favorite